The network of community oncology practices eventually hopes to integrate the tool with its genomic databases.

NEW YORK – Rocket Pharmaceuticals is discussing next steps to complete a pivotal Phase II trial of its Danon disease gene therapy, RP-A501, with the US Food and Drug Administration based on promising ...

The firm's personalized immunotherapy DISP-10 combines an engineered tumor-specific virus with BMS's CAR T-cell therapy Abecma.

NEW YORK – Opus Genetics has enrolled the final patient into its registrational Phase III clinical trial evaluating its investigational gene therapy for a severe, inherited retinal dystrophy, the ...

The firm's approved product Avmapki Fakzynja Co-Pack also returned to sequential growth in Q2 helped by a refocused commercial strategy.

If the FDA approves lonvo-z, Intellia expects it will be able to launch the drug, its first commercial product, in the first ...

NEW YORK – The American Association for Cancer Research on Wednesday announced the launch a Phase II trial testing precision medicines that would allow patients with locally advanced gastroesophageal ...

The firm, founded based on research from Zhejiang University, is partnering with Walvax for logistical support for the investigator-initiated trial.

Meanwhile, revenue from Casgevy reached $76.4 million, marking Vertex and CRISPR Therapeutics' highest quarterly sales from ...